Donate For Public and Patients Store Search

American Academy of Dermatology Logo
Welcome!
Advertisement
Advertisement

Clinical guidance for COVID-19


COVID-19 updates

The Academy’s Ad Hoc Task Force on COVID-19 is monitoring pandemic developments daily, assessing the impact on practices, and providing guidance most relevant to dermatologists. The most current information is being posted to these pages as we have it. Check back for updates.

Access Academy resources designed to answer common dermatology questions during the COVID-19 pandemic.

Recommendations for dermatologists

Review steps you should take to protect yourself, your staff, and your patients.

Dermatological manifestations of COVID-19

Access the Academy's statement on the dermatological manifestations of COVID-19.

PPE and medical supplies

Access Academy advice and FDA guidance on conserving supplies of PPE and other medical supplies.

iPLEDGE and isotretinoin

Read FDA guidance on flexibility in meeting iPLEDGE requirements during the emergency.

Hydroxychloroquine and lupus

Explore updates and advocacy efforts around ensuring appropriate patient access to hydroxychloroquine.

Immunosuppressive therapies

Review information and documents on continuing immunosuppressive therapies during the COVID-19 pandemic.

Academy publications on COVID-19

Access Academy statements and publications on COVID-19, including DermWorld and JAAD articles.

MOC requirements for 2020

The ABD recently announced significant changes to its 2020 MOC requirements for dermatologists in light of the COVID-19 pandemic. Learn more about these changes.

MIPS reporting

CMS has extended the deadline for 2019 MIPS submissions, and is considering how to offer flexibility in 2020.


Navigate the Coronavirus Resource Center


All content solely developed by the American Academy of Dermatology

Supported by: Public>Diseases>Corona>Sponsors

Advertisement
Advertisement